All posts tagged GSK

Pharmaceutical manufacturing

Pharmaceuticals giant GSK increase stake in Indian healthcare unit to 73%

UK drug maker GlaxoSmithKline Plc (LON:GSK) said today it had increased its stake in its Indian unit GlaxoSmithKline Consumer Healthcare Ltd to 72.5% from 43.2%, as part of a voluntary tender offer launched by its subsidiary GlaxoSmithKline Pte Ltd. During …

Continue Reading...
Pharmaceuticals

GSK reaches a deal worth $3.6bn to acquire HGS

British drugmaker GlaxoSmithKline Plc (LON:GSK) reached on Monday a USD3.6bn (EUR2.9bn) deal to buy Human Genome Sciences (NASDAQ:HGSI), or HGS, after it raised its offer for the US

pharmaceutical

Human Genome recommends stockholders reject GSK’s bid

US biopharmaceutical firm Human Genome Sciences (NASDAQ:HGSI), or HGS, reiterated its advice to shareholders not to tender their stock to the $13.00 (EUR10.30) a share hostile takeover offer

Pharma Production

GSK requests board to drop poison pill, blocking takeover of HGS

British drugmaker GlaxoSmithKline Plc (LON:GSK) said it had added as a condition to its USD13.00 (EUR10.35) a share hostile takeover offer for Human Genome Sciences (NASDAQ:HGSI) the request

Pharmaceuticals

HGS’ board urges shareholders not to accept “inadequate” offer from GSK

The board of US biopharmaceutical firm Human Genome Sciences (NASDAQ:HGSI), or HGS, said on Thursday it had determined that the USD13.00 (EUR10.23) a share hostile takeover offer from

Pills

HGS’ board ask shareholders to wait for its recommendation on GSK hostile bid

US biopharmaceutical firm Human Genome Sciences (NASDAQ:HGSI), or HGS, said its board would review the unsolicited USD13.00 (EUR10.03) a share takeover offer from GlaxoSmithKline Plc (LON:GSK) and advised

Powered by WordPress